• Pomalidomide (CC-4047): Optimizing Hematological Malignancy

  2026-04-25

  Pomalidomide (CC-4047) is a cornerstone in hematological malignancy research, uniquely modulating both tumor cells and their microenvironment. This article provides evidence-based protocols, troubleshooting strategies, and insights that empower researchers to maximize assay reproducibility and biological relevance using APExBIO’s trusted reagent.

• Insulin-AMPK Axis Regulates Pink1 mRNA Localization in Neuro

  2026-04-24

  Hees and Harbauer et al. reveal that insulin signaling modulates AMPK activity to govern the localization of Pink1 mRNA at mitochondria, directly influencing PINK1-mediated mitophagy in neurons. This mechanistic insight links metabolic state, phosphorylation signaling, and mitochondrial quality control, with implications for neurodegenerative disease models.

• Dextromethorphan hydrobromide: Technical Guide for Research

  2026-04-24

  Dextromethorphan hydrobromide is a high-purity NMDA receptor antagonist used for controlled studies of neuroprotection, excitotoxicity inhibition, and ion channel modulation in neuroscience research. This compound is intended solely for in vitro and preclinical workflows, and should not be used for diagnostic or clinical purposes.

• Ciprofloxacin Hydrochloride: Beyond Antibacterial to Host Mo

  2026-04-23

  Explore the multidimensional profile of Ciprofloxacin hydrochloride, a leading fluoroquinolone antibiotic. This article uniquely examines its dual antibacterial and immunomodulatory mechanisms, translational relevance, and the latest anti-parasitic research—bridging established applications with emerging scientific frontiers.

• Patient-Derived Gastric Cancer Assembloids Illuminate Tumor-

  2026-04-23

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids and stromal cell subpopulations, capturing the heterogeneity and microenvironmental complexity of primary tumors. The model enables nuanced investigation of drug responses and resistance mechanisms, advancing personalized cancer research.

• Ferroptosis–Apoptosis Interplay and BH3-Mimetic Modulation i

  2026-04-22

  The referenced study reveals that ferroptosis and apoptosis, previously regarded as distinct cell death modalities, can intersect and influence each other under certain cellular stresses. Importantly, BH3-mimetics—including MCL1 inhibitors—modulate this interplay, sometimes enhancing, altering, or even suppressing cell death outcomes. These findings have significant implications for designing combinatorial cancer therapies targeting mitochondrial apoptotic pathways.

• Technical Guide to Angiotensin I/II (1-5) in RAS Research

  2026-04-22

  Angiotensin I/II (1-5) provides a standardized Asp-Arg-Val-Tyr-Ile peptide fragment for precise modeling of the renin-angiotensin system in hypertension and renal research. It should be used exclusively within workflows investigating blood pressure regulation, aldosterone release, or related peptide signaling, and avoided in unrelated peptide signaling studies due to its narrow mechanistic scope.

• Haloprogin: Applied Antifungal Workflows and Troubleshooting

  2026-04-21

  Haloprogin stands out as a research-standard topical antimicrobial agent with potent activity against dermatophytes, Candida albicans, and Gram-positive bacteria. This article delivers actionable protocols, comparative insights, and troubleshooting solutions for leveraging Haloprogin in advanced infection models and antimicrobial assays.

• HyperScript™ Reverse Transcriptase: Precision in Complex RNA

  2026-04-21

  Explore how HyperScript™ Reverse Transcriptase enables robust cDNA synthesis from challenging RNA templates, highlighting unique assay design strategies and critical insights from recent transcriptomics research. This article reveals advanced applications and benchmarks not covered in existing reviews.

• HyperScribe All in One mRNA Synthesis Kit Plus 1: Translatio

  2026-04-20

  Explore how the HyperScribe All in One mRNA Synthesis Kit Plus 1 empowers precision mRNA vaccine development through advanced ARCA capping and immune-evasive modifications. Learn what sets this kit apart for translational and immunological assay innovation.

• Cy3 NHS Ester (Non-Sulfonated): Technical Guide and Protocol

  2026-04-20

  Cy3 NHS ester (non-sulfonated) addresses the need for efficient, sensitive labeling of amino groups in proteins, peptides, and oligonucleotides for imaging and quantification workflows. It is best used in protocols where organic co-solvents are acceptable, but is not recommended for delicate proteins requiring water-only conditions.

• Applied Workflows for Saquinavir: HIV Protease Inhibitor in

  2026-04-19

  Saquinavir stands out in HIV infection research and permeability modeling, supporting robust, high-throughput workflows from virology to oncology. This article details protocol parameters, troubleshooting, and innovations in biomimetic assay design, translating the latest findings into stepwise lab advantages.

• MPC-Mediated Lactate Drives Histone Lactylation in Colorecta

  2026-04-18

  This study reveals how downregulation of mitochondrial pyruvate carrier (MPC) in colorectal cancer elevates lactate production, which in turn increases histone lactylation in dendritic cells, impairing antitumor immunity. These insights highlight metabolic-epigenetic interactions as potential therapeutic targets for improving immunotherapy outcomes.

• Estradiol, ER Stress, and GPR30 in CD4+ T Cell Recovery Afte

  2026-04-17

  This study demonstrates that 17β-estradiol (E2) restores splenic CD4+ T lymphocyte function after hemorrhagic shock by inhibiting endoplasmic reticulum stress, with effects mediated via ERα and GPR30, but not ERβ. These findings clarify receptor-specific pathways in immune recovery post-trauma and provide mechanistic insight for future cardiovascular and immunological research.

• ARCA-Capped mRNA Synthesis: Mechanistic Leverage for Cancer

  2026-04-16

  This thought-leadership article explores the mechanistic advances and translational strategies enabled by ARCA-capped mRNA synthesis—spotlighting the pivotal role of the HyperScribe™ Co-transcription mRNA Synthesis Kit Plus (ARCA, T7) in next-generation vaccine development. Drawing on recent breakthroughs in hepatocellular carcinoma mRNA nanovaccines, the piece provides actionable guidance for translational researchers seeking robust, high-yield workflows that bridge the bench-to-bedside divide.

14931 records 1/996 page Next 12345 下5页 Last page